Knee Arthropathy
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
MedactaSwitzerland - Castel San Pietro
1 programknee total arthroplasty with two types of ancillariesN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Acadia PharmaceuticalsSupport program
Medactaknee total arthroplasty with two types of ancillaries
Clinical Trials (2)
Total enrollment: 50 patients across 2 trials
Knee-hip Surgery Wait-list Support Program
Start: Apr 2025Est. completion: Aug 202650 patients
N/ANot Yet Recruiting
Medico-economic Interest of Single-use Ancillary Efficiency® in Fitting a GMK® Total Knee Arthroplasty (TKA)
Start: Mar 2020Est. completion: Mar 2023
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space